Supernus to Present at Jefferies Virtual Healthcare Conference

Rhea-AI Summary

Supernus Pharmaceuticals (Nasdaq: SUPN) announced that CEO Jack Khattar will present a company overview at the Jefferies Virtual Healthcare Conference on June 1, 2021, at 1:30 p.m. ET. Interested parties can access the live webcast via the company’s Investor Relations page. An archived replay will be available for 60 days post-conference.

Supernus focuses on treatments for central nervous system (CNS) diseases, including epilepsy, migraine, and ADHD among others.

ROCKVILLE, Md., May 25, 2021 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that Jack Khattar, President and CEO of Supernus Pharmaceuticals, will present a company overview at the Jefferies Virtual Healthcare Conference on Tuesday, June 1, 2021, at 1:30 p.m. ET.

A live webcast of the presentation can be accessed by visiting Events & Presentations in the Investor Relations section on the Company's website at www.supernus.com. An archived replay will be available for 60 days on the Company's website following the conference.

About Supernus Pharmaceuticals, Inc.

Supernus Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases.

Our diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, ADHD, hypomobility in Parkinson’s disease, cervical dystonia and chronic sialorrhea. We are developing a broad range of novel CNS product candidates including new potential treatments for hypomobility in Parkinson’s disease, epilepsy, depression, and rare CNS disorders.

For more information, please visit www.supernus.com.

CONTACTS:

Jack A. Khattar, President and CEO
Jim Kelly, Executive Vice President and CFO
Supernus Pharmaceuticals, Inc.
Tel: (301) 838-2591

Or

Investor Contact:
Peter Vozzo
Westwicke/ICR
Office: (443) 213-0505
Mobile: (443) 377-4767
Email: peter.vozzo@westwicke.com

FAQ

What is the date and time of Supernus Pharmaceuticals' presentation at the Jefferies Virtual Healthcare Conference?

Supernus Pharmaceuticals will present on June 1, 2021, at 1:30 p.m. ET.

Where can I watch the Supernus Pharmaceuticals presentation live?

The live webcast can be accessed on the Investor Relations section of the Supernus Pharmaceuticals website.

How long will the replay of the Supernus Pharmaceuticals presentation be available?

The archived replay will be available for 60 days following the conference.

What diseases does Supernus Pharmaceuticals focus on?

Supernus Pharmaceuticals focuses on central nervous system (CNS) diseases, including epilepsy, migraine, ADHD, and more.

Who is presenting for Supernus Pharmaceuticals at the Jefferies Virtual Healthcare Conference?

Jack Khattar, the President and CEO of Supernus Pharmaceuticals, will present at the conference.